News articles

News article list

• Thousands could benefit from treatment for severe alopecia

  New one-a-day tablet for people with severe hair loss due to alopecia areata recommended by NICE

• NICE recommends better targeting of antibiotics for suspected sepsis

  Our guidance recommends better targeting of antibiotics to those at the highest risk of suspected sepsis to ensure the right people receive treatment.

• New treatment for advanced breast cancer recommended by NICE

  Around 300 people are set to benefit following NICE’s recommendation of talazoparib for treating a type of locally advanced or metastatic breast cancer in final draft guidance published today (19 January 2024).

• People at risk of severe COVID-19 to have access to antiviral Paxlovid

  A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be eligible for Paxlovid if they test positive.

• Two technologies to provide digital services for people with COPD

  More people with chronic obstructive pulmonary disease (COPD) could soon access rehabilitation programmes after draft guidance from NICE conditionally recommended two technologies to provide digital services to NHS patients.

• New treatment for cardiovascular disease could benefit millions

  Up to 2.1 million people with cardiovascular disease (CVD) could benefit from a new cholesterol target outlined in NICE guidance for the first time.